Prosecution Insights
Last updated: October 01, 2026

Examiner: COLE, HOUSTON DAVID

Tech Center 1700 • Art Units: 1758 1796

This examiner grants 0% of resolved cases

Performance Statistics

—
Allow Rate
-65.0% vs TC avg
10
Total Applications
—
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

15.7%
§101 Eligibility
19.3%
§102 Novelty
41.0%
§103 Obviousness
20.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18363849 MEASURING METHOD, MEASURING APPARATUS, AND STORAGE MEDIUM Non-Final OA CANON KABUSHIKI KAISHA
18570391 BIOLOGICAL SAMPLE ANALYZER Non-Final OA Sony Group Corporation
18421538 CHARACTERIZATION OF SERINE-LYSINE CROSS-LINK IN ANTIBODY HIGH MOLECULAR WEIGHT SPECIES Non-Final OA Regeneron Pharmaceuticals, Inc.
18533979 CHARACTERIZATION OF GLYCANS AND GLYCOCONJUGATES Non-Final OA Nautilus Subsidiary, Inc.
18697411 DIAGNOSING MULTIPLE SCLEROSIS (MS) Non-Final OA The Regents of the University of Colorado, A Body Corporate
18676468 RESIDUAL ACID ANALYSIS METHOD FOR ALCOHOL COMPOUND Non-Final OA NAN YA PLASTICS CORPORATION
18468585 QUALITY CONTROL SUBSTANCE FOR USE IN THE ANALYSIS OF LEUKOCYTES Non-Final OA ARKRAY, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month